News

Jun 21, 2024

Paul Wender has been awarded the 2024 Biennial Sir Derek Barton Gold Medal by the Royal Society of Chemistry

May 31, 2024

Academician Wender from Stanford, Co-founder of N1 Life, Unveils Latest RNA Delivery Vector for Tunable Liver-Targeted Delivery

May 14, 2024

Women-Led Life Sciences Companies in the Greater Bay Area Ranking List Revealed: N1 Life Was Selected

Apr 17, 2024

36Kr Interview: N1 Life Opens New Path in R&D, Upgrades "Old Drugs" with Peptide Carrier

Apr 10, 2024

The key role of the protein corona: mRNA delivery system undergoes 'identity transformation' in the body, achieving organ targeting | Dr. Janice Zang presentation at BioCon.

Mar 25, 2024

PTAB Supports BioNTech and Pfizer in Initiating Patent Challenge against Moderna | Heavyweights Stand Their Ground, Patent Battle Over mRNA+LNP Technology Reviewed

Mar 18, 2024

N1 Life Showcases Innovation at Bio China 2024 Expo

Mar 8, 2024

Dr. Zang Xiaoyu Was Interviewed by Suzhou TV to Share Her Entrepreneurial Journey

Mar 8, 2024

Women Bloom With Grace, Please Listen to What They Have to Say.

Dec 22, 2023

YDS Pharmatech Launches Data Partner Program with N1 Life, Leveraging Proprietary Peptide Experimental Data to co-develop Generative AI-driven peptide design platform

Oct 18, 2023

N1 Life Hosts Grand Opening for Suzhou Biobay Office

May 17, 2022

Stanford spinout forms drug delivery joint venture with Chinese biotech

Jan 12, 2022

Accuredit Therapeutics and N1 Life Form a Joint Venture Named 'Napoltec', Dedicated to the Development of Therapeutic Drug Delivery Systems and Pressing Ahead Clinical Translation